This document is an excerpt from the EUR-Lex website
Document 62020TN0584
Case T-584/20: Action brought on 15 September 2020 — Cara Therapeutics v EUIPO — Gebro Holding (KORSUVA)
Case T-584/20: Action brought on 15 September 2020 — Cara Therapeutics v EUIPO — Gebro Holding (KORSUVA)
Case T-584/20: Action brought on 15 September 2020 — Cara Therapeutics v EUIPO — Gebro Holding (KORSUVA)
OJ C 390, 16.11.2020, p. 40–40
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
16.11.2020 |
EN |
Official Journal of the European Union |
C 390/40 |
Action brought on 15 September 2020 — Cara Therapeutics v EUIPO — Gebro Holding (KORSUVA)
(Case T-584/20)
(2020/C 390/57)
Language of the case: English
Parties
Applicant: Cara Therapeutics, Inc. (Wilmington, Delaware, United States) (represented by: J. Day, Solicitor and T. de Haan, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Gebro Holding GmbH (Fieberbrunn, Austria)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union word mark KORSUVA — Application for registration No 17 816 844
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 3 July 2020 in Case R 2450/2019-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
uphold the decision of the Opposition Division of 27 January 2018 in Opposition No B 002437922; |
|
— |
allow the contested application to proceed to registration; |
|
— |
order EUIPO and Gebro Holdings GmbH to bear their own costs and pay those of the Applicant. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |